Traditional Chinese medicine composition for preventing and treating viral myocarditis of pets, oral liquid and preparation method of traditional Chinese medicine composition

Abstract

The invention relates to a traditional Chinese medicine composition for preventing and treating viral myocarditis of pets. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 15-35 parts of astragalus, 10-25 parts of herba epimedii, 30-55 parts of Japanese raisin tree fruits, 25-45 parts of mango seeds, 15-30 parts of erigeron breviscapus, 5-20 parts of herba aristolochiae, 10-35 parts of manyleaf paris rhizome, 10-25 parts of hairyvein agrimony and 0.001-0.01 part of VB12. The various medicines are used together, synergistic effects are achieved among the various raw materials, the effects supplement each other, and the medicines interact to achieve effects of nourishing yin and enriching blood, clearing heat and eliminating evil and eliminating free radicals in vivo as soon as possible. Meanwhile, by combining with the vitamin B12, assimilation of the organism is accelerated, and more nutrition and energy can be provided for cardiacmuscle cells. Development and maturation of the whole red blood cells can be promoted, anemia of the body is relieved, exogenous evil can be expelled on the tonifying basis, the aim of treating both symptoms and root causes is achieved, and the viral myocarditis of pets is effectively prevented and treated.

Description

technical field [0001] The invention belongs to the field of traditional Chinese veterinary medicine, and in particular relates to a traditional Chinese medicine composition for preventing and treating pet viral myocarditis, an oral liquid and a preparation method thereof. Background technique [0002] Viral myocarditis is a common disease in pet dogs and cats. It is mainly caused by canine parvovirus, canine distemper virus, infectious hepatitis virus, influenza virus, etc. It occurs mostly in young animals and has a high mortality rate. In clinical practice, supportive therapy based on the combination of antigen-onset virus and relief of clinical symptoms is the main treatment, but the overall treatment effect is not improved, the cure rate is low, and the course of disease is long. Therefore, it is necessary to develop a compound that can not only improve the antiviral effect but also alleviate clinical symptoms, so as to achieve the purpose of treating both symptoms and ...

AI Technical Summary

Problems solved by technology

In clinical practice, the combination of antigen-onset virus combined with supportive therapy to relieve clinical symptoms is the main treatment. The overall treatment effect is not improved, the cure rate is low, and the course of disease is long.

Images